PCNS lymphoma - with haemorrhage

Case contributed by A.Prof Frank Gaillard



Patient Data

Age: 75 years
Gender: Female

Pre and post contrast CT images demonstrate two dominant hyperdense and enhancing lesions; one in the rostral midbrain and the other involving the splenium of the corpus callosum. The former is homogeneous in density and surrounded by moderate surrounding vasogenic oedema. The latter demonstrates haemorrhage. 


Distribution and appearance of the non-haemorrhagic lesion strongly favours CNS lymphoma. Haemorrhage in PCNSL is very uncommon, seen more frequently in immunocompromised individuals. 


Case Discussion

The patient went on to have surgery.


MICROSCOPIC DESCRIPTION: 1&2: Paraffin sections show fragments of cerebral white matter. These are densely infiltrated by a population of atypical large mononuclear cells with round and oval vesicular nuclei, many with conspicuous nucleoli and a variable amount of basophilic cytoplasm. These are arranged in diffuse sheets and are seen to infiltrate the walls of small calibre blood vessels. Scattered mitotic figures are noted. There is prominent reactive astrocytic gliosis in adjacent white matter. Immunohistochemistry shows the atypical cells are CD20+, MUM1+, bcl-2+, bcl-6+, CD23-, CD3-, cyclin D1-, CD10-, EBV-. About 95% of the tumour cells are c-myc immunostain positive. About 50% of the cells are p53 positive.

FINAL DIAGNOSIS: non Hodgkin's large B cell CNS lymphoma - non germinal centre phenotype.


Although haemorrhage in PCNSL is very uncommon, seen more frequently in immunocompromised individuals, the non-haemorrhagic lesion in this case, and the distribution still makes lymphoma the most likely diagnosis. Multicentric high grade glioma would be an alternative ddx. 

PlayAdd to Share

Case information

rID: 43304
Published: 13th Apr 2016
Last edited: 13th Apr 2016
Inclusion in quiz mode: Included

Updating… Please wait.

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.